JP2014511858A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511858A5
JP2014511858A5 JP2014503898A JP2014503898A JP2014511858A5 JP 2014511858 A5 JP2014511858 A5 JP 2014511858A5 JP 2014503898 A JP2014503898 A JP 2014503898A JP 2014503898 A JP2014503898 A JP 2014503898A JP 2014511858 A5 JP2014511858 A5 JP 2014511858A5
Authority
JP
Japan
Prior art keywords
group
isoleucine
cysteine
tyrosine
lysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014503898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014511858A (ja
JP6173298B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/031815 external-priority patent/WO2012138599A2/en
Publication of JP2014511858A publication Critical patent/JP2014511858A/ja
Publication of JP2014511858A5 publication Critical patent/JP2014511858A5/ja
Application granted granted Critical
Publication of JP6173298B2 publication Critical patent/JP6173298B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014503898A 2011-04-02 2012-04-02 治療薬としての肝細胞増殖因子模倣体 Active JP6173298B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161471122P 2011-04-02 2011-04-02
US201161471124P 2011-04-02 2011-04-02
US61/471,124 2011-04-02
US61/471,122 2011-04-02
PCT/US2012/031815 WO2012138599A2 (en) 2011-04-02 2012-04-02 Hepatocyte growth factor mimics as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2014511858A JP2014511858A (ja) 2014-05-19
JP2014511858A5 true JP2014511858A5 (cg-RX-API-DMAC7.html) 2015-05-14
JP6173298B2 JP6173298B2 (ja) 2017-08-02

Family

ID=46969763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014503898A Active JP6173298B2 (ja) 2011-04-02 2012-04-02 治療薬としての肝細胞増殖因子模倣体

Country Status (8)

Country Link
US (3) US9150613B2 (cg-RX-API-DMAC7.html)
EP (1) EP2709650B1 (cg-RX-API-DMAC7.html)
JP (1) JP6173298B2 (cg-RX-API-DMAC7.html)
CN (1) CN103582490B (cg-RX-API-DMAC7.html)
AU (1) AU2012240424B2 (cg-RX-API-DMAC7.html)
CA (1) CA2832113C (cg-RX-API-DMAC7.html)
ES (1) ES2622385T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012138599A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
WO2014021942A1 (en) * 2012-08-01 2014-02-06 University Of Southern California Methods for limiting development of neurodegeneration
WO2014052766A1 (en) * 2012-09-27 2014-04-03 Washington State University Hepatocyte growth factor mimics as therapeutic agents
WO2015120388A1 (en) * 2014-02-10 2015-08-13 Cytori Therapeutics, Inc. Regenerative cell therapy for central nervous system (cns) disorders and ptsd
CN104788537B (zh) * 2015-03-31 2018-03-13 中国科学院长春应用化学研究所 一种四肽化合物及其制备方法和应用
SI3464336T1 (sl) * 2016-06-01 2022-06-30 Athira Pharma, Inc. Spojine
GB201611123D0 (en) 2016-06-27 2016-08-10 Euremab Srl Anti met antibodiesand uses thereof
CN106699868B (zh) * 2017-03-01 2019-11-15 牡丹江医学院 一种蛋白质及编码其的核苷酸序列
IT201800000535A1 (it) 2018-01-03 2019-07-03 Procedimenti per la cura del cancro.
CN110716925B (zh) * 2019-09-05 2023-08-04 中电科大数据研究院有限公司 一种基于轨迹分析的跨境行为识别方法
US20230000943A1 (en) * 2021-06-29 2023-01-05 Synaptogenix, Inc. Method of inducing synaptogenesis by administering angiotensin and analogues thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662130B1 (en) 1992-09-18 1997-11-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES A method of producing hepatocyte growth factor and a cell line
US5854388A (en) * 1993-06-24 1998-12-29 Washington State University Research Foundation Angiotensin IV peptides and receptor
US6777388B1 (en) * 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US7192976B2 (en) * 2002-12-21 2007-03-20 Angion Biomedica Corporation Small molecule modulators of hepatocyte growth factor (scatter factor) activity
EP2043675A2 (en) * 2006-07-07 2009-04-08 Washington State University Research Foundation C-met receptor regulation by angiotensin iv (at4) receptor ligands
WO2011019400A2 (en) * 2009-08-12 2011-02-17 Angion Biomedica Corp. Enhancement of cellular transplantation using small molecule modulators hepatocyte growth factor (scatter factor) activity

Similar Documents

Publication Publication Date Title
AU2015349969B2 (en) Methods of manufacturing treprostinil and treprostinil derivative prodrugs
JP2013537194A5 (ja) 疾患を治療するための医薬品及び同医薬品を含むキット
JP2013537195A5 (ja) 疾患を治療するための医薬品及び同医薬品を含むキット
JP2002526454A5 (cg-RX-API-DMAC7.html)
EP0626174A2 (en) Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
BR112015004854A2 (pt) novo composto com efeitos de trombólise, eliminação de radical livre e direcionamento ao trombo bem como método de preparação e uso do mesmo
US20020131932A1 (en) Radiopharmaceuticals for diagnosing alzheimer's disease
JP2019065044A (ja) 神経疾患を治療するための方法
US20140088004A1 (en) Hepatocyte Growth Factor Mimics as Therapeutic Agents
DK1712223T3 (da) Farmaceutisk præparat af rekombinant faktor VIII lyofiliseret uden albumin som stabilisator
KR20200022435A (ko) 펩타이드 조성물 및 관련된 방법
WO2009068708A2 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
JP6580581B2 (ja) 注射用医薬組成物
US20140094413A1 (en) Hepatocyte growth factor (hgf) mimics as therapeutic agents
BR112019019720A2 (pt) agonistas de npra, composições e usos dos mesmos
DE585300T1 (de) Galaninantagonist.
EP0647449A1 (en) Sustained-release preparation of anti-endothelin substance
RU2013146690A (ru) Циклические пептиды с антинеопластической и антиангионенной активностью
DE69931010T2 (de) Peptide mit osteogener Aktivität
US9051351B2 (en) Hepatocyte growth factor mimics as therapeutic agents
JPH0463049B2 (cg-RX-API-DMAC7.html)
US20190290726A1 (en) Protein polymer fusions for subcutaneous delivery of small molecules
JPWO2003039577A1 (ja) ドライアイおよびドライアイを伴う疾病の治療剤
JP2020520393A5 (cg-RX-API-DMAC7.html)
TW202132334A (zh) Cxcr4拮抗劑肽